Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 17.5
(-0.91%)
CNY 17.5
(-0.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 566.39 Million | 604.57 Million | 590.88 Million | 468.11 Million | 464.8 Million | 437.3 Million |
| Cost of Revenue | 441.27 Million | 466.35 Million | 434.97 Million | 361.49 Million | 333.11 Million | 306.32 Million |
| Gross Profit | 125.12 Million | 138.21 Million | 155.91 Million | 106.62 Million | 131.68 Million | 130.97 Million |
| Operating Expenses | 96.57 Million | 85.28 Million | 83.47 Million | 40.7 Million | 38.84 Million | 44.29 Million |
| Selling, General and Administrative Expenses | 54.6 Million | 19.98 Million | 24 Million | -2.66 Million | -36.13 Million | -25.33 Million |
| Research and Development Expenses | 38.09 Million | 45.14 Million | 37.12 Million | 21.6 Million | 26.05 Million | 27.1 Million |
| Other Expenses | 3.87 Million | -389.83 Thousand | 23.4 Million | 10.06 Million | 36.65 Million | 31.96 Million |
| Cost and Expenses | 546.86 Million | 551.64 Million | 518.44 Million | 402.19 Million | 371.95 Million | 350.61 Million |
| Operating Income | 19.52 Million | 38.9 Million | 62.71 Million | 57.3 Million | 79.69 Million | 78.33 Million |
| Interest Expense | 13.55 Million | 13.37 Million | 5.17 Million | 13.5 Million | 23.34 Million | 23.97 Million |
| Income Tax Expense | -2.17 Million | -982.33 Thousand | 8.05 Million | 7.04 Million | 9.81 Million | 9.7 Million |
| Earnings before Tax | 19.11 Million | 38.51 Million | 86.11 Million | 60.24 Million | 82.81 Million | 80.38 Million |
| Net Income | 23 Million | 40.2 Million | 78.33 Million | 53.28 Million | 72.99 Million | 70.67 Million |
| Earnings Per Share Basic | 0.20 | 0.35 | 0.68 | 0.46 | 0.63 | 0.84 |
| Earnings Per Share Diluted | 0.20 | 0.35 | 0.68 | 0.46 | 0.63 | 0.84 |
| Weighted Average Shares Outstanding | 115.02 Million | 115.27 Million | 115.27 Million | 115.27 Million | 115.27 Million | 84.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 115.02 Million | 115.27 Million | 115.27 Million | 115.27 Million | 115.27 Million | 84.14 Million |
| Gross Margin | 0.22 | 0.23 | 0.26 | 0.23 | 0.28 | 0.30 |
| EBIT Margin | 0.11 | 0.14 | 0.20 | 0.21 | 0.28 | 0.28 |
| Profit Margin | 0.04 | 0.07 | 0.13 | 0.11 | 0.16 | 0.16 |
| EBITDA | 60.5 Million | 79.11 Million | 116.39 Million | 88.17 Million | 104.76 Million | 100.32 Million |
| Earnings Before Tax Margin | 0.03 | 0.06 | 0.11 | 0.12 | 0.17 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 131.56 Million | 111.25 Million | 122.22 Million | 181.36 Million | 566.39 Million | 117.21 Million |
| Cost of Revenue | 120.23 Million | 100.86 Million | 95.86 Million | 144.92 Million | 441.27 Million | 88.28 Million |
| Gross Profit | 11.33 Million | 10.38 Million | 26.36 Million | 36.44 Million | 125.12 Million | 28.93 Million |
| Operating Expenses | 27.34 Million | 20.01 Million | 21.48 Million | 17.9 Million | 83.35 Million | 22.37 Million |
| Selling, General and Administrative Expenses | 33.46 Million | 15.28 Million | 13.89 Million | -14.64 Million | - | 28.98 Million |
| Research and Development Expenses | 11.95 Million | 9.29 Million | 9.5 Million | 7.78 Million | - | 9.27 Million |
| Other Expenses | -18.07 Million | 4.57 Million | -299.56 Thousand | -3.88 Million | -413.68 Thousand | 95.1 Thousand |
| Cost and Expenses | 147.57 Million | 120.88 Million | 117.35 Million | 162.82 Million | 524.63 Million | 110.65 Million |
| Operating Income | -17.08 Million | -9.62 Million | 2.23 Million | 4.44 Million | 19.52 Million | 4.09 Million |
| Interest Expense | 5.45 Million | 5.03 Million | 3.36 Million | 3.18 Million | 13.18 Million | 2.89 Million |
| Income Tax Expense | -5.34 Million | -3.49 Million | -957.39 Thousand | 642.36 Thousand | -2.17 Million | -558.22 Thousand |
| Earnings before Tax | -14.98 Million | -13.64 Million | 1.93 Million | 555.59 Thousand | 19.11 Million | 4.18 Million |
| Net Income | -9.04 Million | -8.66 Million | 3.54 Million | 220.53 Thousand | 23 Million | 5.31 Million |
| Earnings Per Share Basic | -0.08 | -0.08 | 0.03 | 0.05 | - | 0.05 |
| Earnings Per Share Diluted | -0.08 | -0.08 | 0.03 | 0.05 | - | 0.05 |
| Weighted Average Shares Outstanding | 115.27 Million | 115.27 Million | 118.24 Million | 113.57 Million | 115.02 Million | 115.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 115.27 Million | 115.27 Million | 118.24 Million | 113.57 Million | 115.02 Million | 115.27 Million |
| Gross Margin | 0.09 | 0.09 | 0.22 | 0.20 | 0.22 | 0.25 |
| EBIT Margin | -0.07 | -0.02 | 0.04 | 0.08 | - | 0.06 |
| Profit Margin | -0.07 | -0.08 | 0.03 | 0.00 | 0.04 | 0.05 |
| EBITDA | -9.53 Million | -1.8 Million | 4.94 Million | 14.83 Million | - | 6.72 Million |
| Earnings Before Tax Margin | -0.13 | -0.09 | 0.02 | 0.02 | 0.03 | 0.03 |
4845
MGRM
300554
DXC
STYLAMIND
KKCL